Data – The Catch-All Solution for Costly Clinical Trials?
With clinical trials having become extremely expensive to conduct, industry buzz around the potential of data and artificial intelligence (AI) to…
Tagged with Data
Tom O’Leary – CIO, ICON
In an exclusive and wide-ranging interview, Tom O’Leary, chief information officer (CIO) of leading contract research organisation (CRO), ICON,…
Creating a Data-Driven Research Ecosystem with Patients at the…
Health Catalyst’s Elia Stupka explains why and how patients must be kept at the centre of the healthcare systems of the future, even as they become…
Tending the Garden of RWD via Project EHDEN: 21st Century Tools…
Nigel Hughes of the European Health Data & Evidence Network (EHDEN) outlines EHDEN’s scope and purpose and highlights why greater…
Hot Topics in Swedish Pharma
We recently analysed the contents of 20 interviews conducted with country managers at multinational pharma companies in Sweden and found some…
Sweden’s Quality Registries: A Gold Mine of Real-World…
Thanks to the cooperation of its citizens, Sweden boasts a comprehensive patient registry of electronic health records. Multinational pharma companies…
Olivia Wigzell – Director-General, National Board of Health…
The National Board of Health and Welfare is the public authority responsible for ensuring that people have access to good health and social care on…
Jim Xu – General Manager, Medidata China
Jim Xu, GM of Medidata China, shares the importance of the China market to Medidata Solutions, the global leader in cloud services and solutions to…
Kris Sterkens – Company Group Chairman, Janssen EMEA
In this exclusive and wide-ranging interview, Janssen’s EMEA head Kris Sterkens outlines the company’s strategies in Europe, its increasing…
Transitioning Pharma’s Data Supply Chain into the 21st Century
An examination of the evolution of the pharma data supply chain and the vital importance of establishing trust with patients to access complete…
Richie Etwaru – Human Data Ethicist & CEO,…
These insights come from Richie Etwaru, the CEO of Hu-Manity.co, known for pursuing the 31st Human Right “everyone has the right to legal ownership…
Pharma Must Embrace Real-World Evidence to Remain Competitive
Holmusk’s Nawal Roy highlights the increasing recognition of the value of real-world evidence (RWE) by both innovative pharma companies and drug…
